[{"from": "human", "value": "Could you give me a brief overview of this molecule? [C][O][C][=Branch1][C][=O][C@H1][Branch1][#Branch2][C][=C][C][=C][C][=C][Ring1][=Branch1][Cl][N][C][C][C][=C][Branch1][Ring2][C][Ring1][=Branch1][C][=C][S][Ring1][=Branch1]"}, {"from": "gpt", "value": "The molecule is a prodrug of a platelet inhibitor used to reduce the risk of myocardial infarction and stroke. Clopidogrel is indicated to reduce the risk of myocardial infarction for patients with non-ST elevated acute coronary syndrome (ACS), patients with ST-elevated myocardial infarction, and in recent MI, stroke, or established peripheral arterial disease,  It has been shown to be superior to [aspirin] in reducing cardiovascular outcomes in patients with cardiovascular disease and provides additional benefit to patients with acute coronary syndromes already taking aspirin.  Clopidogrel was granted FDA approval on 17 November 1997."}]